Continuation vs Discontinuation of Renin-Angiotensin System Inhibitors Before Major Noncardiac Surgery: The Stop-or-Not Randomized Clinical Trial
Matthieu Legrand,Jérémy Falcone,Bernard Cholley,Hélène Charbonneau,Amélie Delaporte,Adrien Lemoine,Matthias Garot,Alexandre Joosten,Claude Meistelman,Delphine Cheron-Leroy,Jean-Philippe Rives,Bruno Pastene,Antoine Dewitte,Stéphanie Sigaut,Marc Danguy des Deserts,Cyrille Truc,Matthieu Boisson,Sigismond Lasocki,Philippe Cuvillon,Ugo Schiff,Samir Jaber,Morgan Le Guen,Anaïs Caillard,Stéphane Bar,Edmundo Pereira de Souza Neto,Vincent Colas,Florin Dimache,Thibaut Girardot,Elsa Jozefowicz,Simon Viquesnel,Francis Berthier,Eric Vicaut,Etienne Gayat,Stop-or-Not Trial Group,Simon Monziols,Mylene Defaye,Thibault Camus,Jean-Jacques Robin,Alexandre Ouattara,Ioana Fetita,Olivier Joannes-Boyau,Eline Bonnardel,Rémi Bouquerel,Antoine Strzelecki,Thibaut Fayon,Christophe Pelletier,Benjamin LE Gaillard,Géraud Amoussou,Maalik El Bouyousfi,Bruno Ganascia,Calliope Butrulle,Soizic Gergaud,Pierre Habrial,Solène Pessiot,Emmanuel Samson,Caroline Wolff,Nevena Stankova,Farida Aouati,Juliette Kavafyan,Vlad Suparschi,Dan Longrois,Julie LE Roy,Benoit Rossignol,Olivier Huet,Christophe Boisson,Pierre Olivier Bonnin,Mohamed Dhaouadi,Ghislaine Gardes,Mikael Perin,Sophie Brunet,Yann Gricourt,Marc-Olivier Fischer,Stéphane Debroczi,Lucie Retournay,Pierre Strub,Patrice Vivin,Rachel Dupays,Thomas Kerforne,Gabriel Vianet,Virginie Manzano,Eric Noll,Pierre-Olivier Ludes,Thien-Nga Chamaraux-Tran,Cédric Cirenei,Djihad Hamroun,Benoit Lebas,Grégoire Andrieu Andrieu,Vincent Etienne,Raphaël Cinotti,Natacha Simon,Denis Frasca,Hélène Beloeil,Amandine LE Gall,Petyo Techev,Ludovic Meuret,Jérémie Joffre,Hervé Dupont,Beny Charbit,Arthur Davy,David Lobo,Jean-Michel Devys,Benjamin Soria,Clémentine Cholet,Cyrus Motamed,Anne Wyniecki,Valérie Billard,Migena Demiri,Clement Millet,Samuel Degoul,Christophe Canevet,Céline Mounier,Flavie Desrumaux,Julia Martinez,Claire Texier,Benoit Voisin,Guillaume Dubreuil,Jacques DE Montblanc,Claire Mengelle,Laura Ruscio,Emmanuel Futier,Julie Fayon,Benoit Baietto,Marie Vignaud,Yoann Munier,Bertille Paquette,Diana Saptefrat,Zakia Machroub,Jean-Sébastien Aubert,Georges Abi Abdallah,Nicolas Polge,Najla Dachraoui,Anne Godier,Diane Zlotnik,Hélène Nougue,Darless Clausse,Sabrina Ma,Sherifatou Salami-Adjavon,Patrick Rossignol,Romain Barthélémy,Damien Logeart,Peggy Reiner,Karine Pautrat,Alex Hong,Marine Coroir,Claire Mayeur,Jacques Thes,Florent Laverdure,Sofiane Seri,Violeta Bercan,Cristian Radu Ionescu,Caroline Gonnet Pinton,Marc Leone,Nathalie Lesavre,Jeanne Chatelon,Marion Poirier,Adrien Rivory,Stéphanie Roullet,Sean Coeckelenbergh,Leila Toubal,Joanna Ramadan,Karine Nouette-Gaulain,Bruno Ralec,Chloé Thill,Christophe Giacardi,Etienne Montelescaut,Philippe Aries,Benoît Tavernier,Julie Bellet,Romain Delassus,Hélène Tribouillard,Daniel Verzilli,Alice Millot,Audrey DE Jong,Marie Geniez,Virginie Marre,Michaëla Penne,Yvan Pouzeratte,Guillaume Rao,Maxime Coutrot,Alice Blet,Benoit Plaud,Emmanuel Basto,Mathilde Ponsin,Marie-Christine Becq,Maïté Chaussard,Aristide Ntahe,François Depret,Lucie Guillemet,Arnaud Valent,Lyse Flores,Julien Burey,Sarah Feray,Yoann Elmaleh,Sophie Dupeyrat,Thomas Baury,Clémentine Taconet,Thomas Rimmele,Elodie Mazocky,Marie Luce Parrouffe,Catherine Jadaud,Stanislas Abrard,Pierre-Antoine Tronche,Arthur Vial,Emma Aka,Anne-Sophie Bellocq,Jean-François Carabalona,Blandine Fayard,Jean Marie Guyader,Letitia Huriaux,Ingrid Millot,Antoine Lamblin,Marine Dutour,Mathilde Roukhomovsky-Moretti,Pascal Meuret,Nadir Omrani,Barnabé Raymond,Clemence Roy,Florent Sigwalt,Xavier Merindol,Mathieu Desmard,Louis Bourreau,Pierre-Antoine Allain,Charlotte Dei Svaldi,Brenton Alexander
DOI: https://doi.org/10.1001/jama.2024.17123
IF: 11.816
2024-09-24
JAMA
Abstract:Importance: Before surgery, the best strategy for managing patients who are taking renin-angiotensin system inhibitors (RASIs) (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) is unknown. The lack of evidence leads to conflicting guidelines. Objective: To evaluate whether a continuation strategy vs a discontinuation strategy of RASIs before major noncardiac surgery results in decreased complications at 28 days after surgery. Design, setting, and participants: Randomized clinical trial that included patients who were being treated with a RASI for at least 3 months and were scheduled to undergo a major noncardiac surgery between January 2018 and April 2023 at 40 hospitals in France. Intervention: Patients were randomized to continue use of RASIs (n = 1107) until the day of surgery or to discontinue use of RASIs 48 hours prior to surgery (ie, they would take the last dose 3 days before surgery) (n = 1115). Main outcomes and measures: The primary outcome was a composite of all-cause mortality and major postoperative complications within 28 days after surgery. The key secondary outcomes were episodes of hypotension during surgery, acute kidney injury, postoperative organ failure, and length of stay in the hospital and intensive care unit during the 28 days after surgery. Results: Of the 2222 patients (mean age, 67 years [SD, 10 years]; 65% were male), 46% were being treated with angiotensin-converting enzyme inhibitors at baseline and 54% were being treated with angiotensin receptor blockers. The rate of all-cause mortality and major postoperative complications was 22% (245 of 1115 patients) in the RASI discontinuation group and 22% (247 of 1107 patients) in the RASI continuation group (risk ratio, 1.02 [95% CI, 0.87-1.19]; P = .85). Episodes of hypotension during surgery occurred in 41% of the patients in the RASI discontinuation group and in 54% of the patients in the RASI continuation group (risk ratio, 1.31 [95% CI, 1.19-1.44]). There were no other differences in the trial outcomes. Conclusions and relevance: Among patients who underwent major noncardiac surgery, a continuation strategy of RASIs before surgery was not associated with a higher rate of postoperative complications than a discontinuation strategy. Trial registration: ClinicalTrials.gov Identifier: NCT03374449.